209984-34-9

Basic information

• Product Name: (R)-5-(N-Boc-L-alaninyl)amino-7-methyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one
• CAS NO: 209984-34-9
• Molecular Weight: 409.485
• Mol File: 209984-34-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (R)-5-(N-Boc-L-alaninyl)amino-7-methyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-5-(N-Boc-L-alaninyl)amino-7-methyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one(209984-34-9)
• EPA Substance Registry System: (R)-5-(N-Boc-L-alaninyl)amino-7-methyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one(209984-34-9)

Safety Data

• Hazardous Substances Data: 209984-34-9(Hazardous Substances Data)

Upstream product

• 15761-38-3 L-N-Boc-Ala 
• 213024-76-1 7-amino-5-methyl-5H-dibenzo[b,d]azepin-6(7H)-one hydrochloride 
• 209984-32-7 7-amino-5-methyl-5H-dibenzo[b,d]azepin-6(7H)-one hydrochloride 

Downstream Products

• 253324-50-4 C₁₈H₁₉N₃O₂ 

Relevant articles and documents

CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS

Disclosed are compounds which inhibit beta -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits beta -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.